Lipid Profiles & NSW LCDR Jim Mucciarone NSWG-2 16 July 2008.

Slides:



Advertisements
Similar presentations
The Skinny on Trans Fats
Advertisements

Meredith Cook Mercer COPHS August,2012. Total Cholesterol HDL Could CVD prediction be improved by also assessing additional lipid-related markers (replacing.
Time line of data collection in the Nurses’ Health Study, 1988 to 2000 A. Heather Eliassen et al, Arch Intern Med. 2005; 165:
Definitions Body Mass Index (BMI) describes relative weight for height: weight (kg)/height (m 2 ) Overweight = 25–29.9 BMI Obesity = >30 BMI.
Cardio-Metabolic Syndrome Guidelines on Education, Detection and Early Treatment  Heval Mohamed Kelli, PGY-2 Emory Internal Medicine Residency no conflict.
New concepts and guidelines in the management of LDL-c and CV Risk: Need for early intervention Prof. Ulf Landmesser University Hospital Zürich Switzerland.
Lipid Disorders and Management in Diabetes
The Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) The LIPID Study Group N Engl J Med 1998;339:
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program Clinical Goals for the Healthy.
Diagnosis and Treatment of Dyslipidemia  New guidelines are based on the “Adult Treatment Plan III (ATP III)” 2004  Focus = multiple risk factor assessment.
Facts and Fiction about Type 2 Diabetes Michael L. Parchman, MD Department of Family & Community Medicine September 2004.
Morteza Naghavi, M.D. Founder Society for Heart Attack Prevention and Eradication (SHAPE) SHAPE Guidelines Prevention of Fatal Cardiovascular Events (Heart.
LDL Cholesterol Goals and Cutpoints for Therapeutic Lifestyle Changes (TLC) and Drug Therapy in Different Risk Categories Risk Category LDL Goal (mg/dL)
LIPID LOWERING IN T2D (The Lower the Better?) CONS… TARGETING HARD CVD END POINTS Charles SAAB MD Consultant Endocrinologist DCRP Sacre-Coeur University.
How Much Exercise Is Necessary to Prevent CV Disease? Thomas G. Allison, PhD, MPH Mayo Clinic, Rochester, MN, USA.
Cholesterol. CHOLESTEROL What is it? How does it cause heart disease? A fat like substance in your blood When there is too much cholesterol in your blood,
{ A Novel Tool for Cardiovascular Risk Screening in the Ambulatory Setting Guideline-Based CPRS Dialog Adam Simons MD.
* Plus–minus values are means ±SD. † Race was determined by the investigator. ‡ The body-mass index is the weight in kilograms divided by the square of.
 High density lipoproteins (HDL) protect against cardiovascular disease  A novel mechanism for raising HDL levels is to inhibit a protein known as CETP.
Women and Cholesterol What You Need to Know. Age: 45 Women and Cholesterol: What You Need to Know HDL: 60 mg/dL and above LDL: Below 100 mg/dL GoodBad.
HYPERLIPIDAEMIA. 4S 4444 patients –Hx angina or MI –Cholesterol Simvastatin 20mg (10-40) vs. placebo FU 5 years  total cholesterol 25%;  LDL.
Department of Family & Community Medicine
Nutrition and Cardiovascular Disease. Cardiovascular Disease Includes heart attack, stroke Includes heart attack, stroke Leading cause of death in the.
Lipid Lowering Substudy Trial of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial JAMA 2002;288: ALLHAT- LLT.
Slide Source: Lipids Online Slide Library Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)
Kotseva K, et al. Eur J Cardiovasc Prev Rehabil 2009 Mar 12 [Epub]
Modern Management of Cholesterol in the High-Risk Patient.
Fenofibrate Intervention and Event Lowering in Diabetes FIELDFIELD Presented at The American Heart Association Scientific Sessions, November 2005 Presented.
Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Trial MEGA Trial Presented at The American Heart Association.
Cholesterol and Triglycerides. What are triglycerides? Type of lipid found in your blood Store unused calories in your fat cells Hormones release triglycerides.
Taipei Medical University. Adolescents with Higher Althernate Healthy Eating Index For Taiwan (AHEI-T) Scores Have Lower Blood Lipid Level De-Zhi Weng,
Dyslipidemia.  Dyslipidemia is elevation of plasma cholesterol, triglycerides (TGs), or both, or a low high- density lipoprotein level that contributes.
© 2003, Wellsource Inc. Effect of Ketogenic Diet on Lipid Levels (shown is LDL-C) In this group of 141 children followed for 6 months, a ketogenic diet.
Pai JK et al. N Engl J Med 2004; 351: Relative CHD risk by increasing baseline CRP plasma levels,* relative to CRP
The Prospective Pravastatin Pooling Project L I P I D CARECARE PPP Project Investigators Am J Cardiol 1995; 76:899–905.
WOSCOPS: West Of Scotland Coronary Prevention Study Purpose To determine whether pravastatin reduces combined incidence of nonfatal MI and death due to.
Cholesterol. What is cholesterol? Waxy, fat-like substance found in all cells. Dietary cholesterol – found only in animal-based foods Blood cholesterol.
Diabetes and High Blood Pressure Are Like Twins. Ignoring Your High Blood Pressure.
7/27/2006 Outcomes in Hypertensive Black and Nonblack Patients Treated with Chlorthalidone, Amlodipine, and Lisinopril* * Wright JT, Dunn JK, Cutler JA.
 2010 Cengage-Wadsworth Preventing Cardiovascular Disease Chapter 11.
4S: Scandinavian Simvastatin Survival Study
Unnecessary Lipid Screening of Inpatient Admissions Dennis Whang 4/2/12 DSR2.
Cholesterol Measurement All adults should have their blood cholesterol measured every 5 years May be in non-fasting state Fasting preferred
Cholesterol-lowering effects of a stanol- ester containing low-fat margarine used in conjunction with a strict lipid-lowering diet Andersson A et al. Eur.
1. Be sure to know where to find information for physician guidelines and how to access their websites. Ex: USPSTF, NHLBI, AHA 2. Be familiar with recommendations.
Case 1: Elevated LDL-C in a Young Adult. Page 2 of 10 *DALY; disability-adjusted life years Routine checkup:  Age:33 years  Sex: male  Status: Except.
HEARTS & MINDS Lowering Cholesterol with Plant Stanol Ester Opening Remarks Herbert Schuster, M.D., Ph.D. Humboldt University Berlin, Berlin, Germany.
Dufaux, International Journal of Sports Medicine, 1982 TRIGLYCERIDES & TRAINING Increase Decrease No Change Numbers of Studies.
Copyright © 2015 by the American Osteopathic Association.
Therapeutic Lifestyle
Title slide.
Triglycerides Cholesterol HDL-C or N NIDDM N or or N IDDM.
V. Atella, A. Brady, A. L. Catapano, J. Critchley, I. M. Graham, F. D
First time a CETP inhibitor shows reduction of serious CV events
Copyright © 2012 American Medical Association. All rights reserved.
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults Risks and Assessment NHLBI Obesity Education.
National Cholesterol Education Program
Oxford Niacin Trial.
Jane Armitage on behalf of the HPS2-THRIVE Collaborative Group
Type 2 diabetes: Overlap of clinical conditions
Rational Order of Laboratory Tests in Cardiovascular Diseases
Level of risk factor control in the overall sample and by gender
Goals & Guidelines A summary of international guidelines for CHD
Baseline Demographic Characteristics of Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al.
Change in (A) total cholesterol; (B) LDL-cholesterol; (C) HDL-cholesterol and (D) triglycerides over 5 years in response to 12-week intensive lifestyle.
PROSPER: trial design                                                                                                                                                                 
Adjusted relative risk Adjusted odds ratio
Individual lipid measures for high-carbohydrate (n=10) and low-carbohydrate (n=10) ultra-endurance athletes. Individual lipid measures for high-carbohydrate.
Kaplan-Meir survival plots for CHD mortality (A), CVD mortality (B), and all-cause mortality (C) in men grouped by TG/HDL-C ratio of 3.5. Kaplan-Meir survival.
Percentage of total mortality cases from CHD, CVD, and other causes (A). Percentage of total mortality cases from CHD, CVD, and other causes (A). Mortality.
Presentation transcript:

Lipid Profiles & NSW LCDR Jim Mucciarone NSWG-2 16 July 2008

Study Reviewed age, height, weight, total cholesterol, LDL, HDL and Triglycerides in 85 SEAL physicals conducted in CY Reviewed age, height, weight, total cholesterol, LDL, HDL and Triglycerides in 85 SEAL physicals conducted in CY Compared results with ATP-III standards for Cholesterol and LDL. Compared results with ATP-III standards for Cholesterol and LDL. Target for cholesterol < 200 mg/dl Target for cholesterol < 200 mg/dl Target for LDL < 130 mg/dl Target for LDL < 130 mg/dl

Results Avg Age: (21-52) Avg Age: (21-52) Avg Cholesterol: ( ) Avg Cholesterol: ( ) Avg LDL: (70-221) Avg LDL: (70-221) 22/85 (25.9%) Total Chol > /85 (25.9%) Total Chol > /85 (27.1%) LDL > /85 (27.1%) LDL > 130

Biases Age Age 5 years AD, Retirement Physicals included 5 years AD, Retirement Physicals included Medications Medications Excluded personnel known to be on meds Excluded personnel known to be on meds Fasting Fasting Assumed patients fasted appropriately Assumed patients fasted appropriately

Significance Increased serum cholesterol significantly associated with increased risk of death before age 50 (Klag, et al, NEJM, 1993) Increased serum cholesterol significantly associated with increased risk of death before age 50 (Klag, et al, NEJM, 1993) Men 200 have increased overall mortality Men 200 have increased overall mortality > 240 = 2.10 to 3.63 RR of CHD or CVD death > 240 = 2.10 to 3.63 RR of CHD or CVD death Men < 39 y/o with chol < 200 = 3.8 to 8.7 years of life (Stamler, et al, JAMA, 2000) Men < 39 y/o with chol < 200 = 3.8 to 8.7 years of life (Stamler, et al, JAMA, 2000) “Grow the Force” “Grow the Force”

Treatment Therapeutic Lifestyle Changes Therapeutic Lifestyle Changes Reduce Sat Fats/Cholesterol Reduce Sat Fats/Cholesterol Reduce Body Weight Reduce Body Weight Increase stanols/sterols and fiber Increase stanols/sterols and fiber Increase physical activity Increase physical activity Prefer to avoid statins Prefer to avoid statins Lifelong medication Lifelong medication Assoc with muscle pain Assoc with muscle pain